Alligator Bioscience AB Logo

Alligator Bioscience AB (7AL0)

FSX

Currency in EUR
0.000100
0.00 (0.00%)

Closed

Sep 18, 2026

Day's Range

0.000100
0.000100

52 wk Range

0.000043
0.4591

Overview - 7AL0 - Alligator Bioscience AB

Key Statistics

Valuation

Enterprise Value

-18.95M

P/E (Trailing)

‪0.000020‬

PEG Ratio

‪0.00000036‬

Price / Sales (TTM)

‪0.17‬

Price / Book

‪0.01‬

EV / EBITDA

‪0.16‬

Profitability

Profit Margin

‪0.00%‬

Operating Margin

‪-1,378.01%‬

Return on Assets

‪-89.52%‬

Return on Equity

‪-748.65%‬

Ownership

Shares Outstanding

628.10M

Float

613.86M

Held by Insiders

‪1.65%‬

Held by Institutions

‪2.88%‬

Price stats

Beta

‪1.17‬

50-Day Avg

‪0.00131‬

200-Day Avg

‪0.00494‬

Dividends

Payout Ratio

‪0.00%‬

News Teaser - 7AL0 - Alligator Bioscience AB

News & Analysis

View all news

Market Cap - 7AL0 - Alligator Bioscience AB

Peers - 7AL0 - Alligator Bioscience AB

Peer Comparison

Compared with companies in Biotechnology listed on FSX.

Profile Summary - 7AL0 - Alligator Bioscience AB

About

Alligator Bioscience AB is a clinical-stage biotechnology company focused on developing tumor-directed immuno-oncology antibody drugs, particularly those targeting the CD40 receptor pathway. Its primary purpose is to activate the patient's immune system directly within the tumor microenvironment, overcoming immune…

SectorHealthcare
IndustryBiotechnology
Employees11
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.